Table 1.
Vaccine design | Number of candidates |
---|---|
Whole virus | |
Live attenuated | 2 |
Inactivated | 12 |
Viral vector | |
Replicating | 4 (VSV, measles virus, and influenza virus) |
Non-replicating | 14 (adenovirus 5, adenovirus 26 and MVA) |
Protein subunit | 29 |
Virus like particle | 5 |
Nucleic acid | |
RNA | 13 |
DNA | 10 |
Antigen presenting cells with replicating viral vector | 1 |
Antigen presenting cells with non-replicating viral vector | 2 |
WHO candidate vaccines, reference [26]. VSV, vesicular stomatitis virus; MVA, modified vaccinia virus Ankara.